NOTCH2NLC Gene

Migration, Crosslink

📖

NOTCH2NLC Gene

active

wiki page Created: 2026-04-02T07:19:22 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-notch2nlc

📖 Wiki Page

gene1752 wordssynced 2026-04-02

NOTCH2NLC Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">NOTCH2NLC Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>NOTCH2NLC</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Notch 2 N-terminal-like protein</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>1q12</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>100302521</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000237289</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9P0M4</td>
</tr>
<tr>
<td class="label">Gene Type</td>
<td>Protein-coding</td>
</tr>
<tr>
<td class="label">Transcript Length</td>
<td>2,451 bp</td>
</tr>
</table>

NOTCH2NLC (Notch 2 N-terminal-like protein) is a gene located on chromosome 1q12 that encodes a protein member of the Notch receptor family. The gene harbors a GGC repeat in its 5'UTR region, and pathogenic expansions of this repeat cause neuronal intranuclear inclusion disease (NIID) and have been associated with other neurodegenerative disorders including [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), [frontotemporal dementia](/diseases/frontotemporal-dementia), and [amyotrophic lateral sclerosis](/diseases/amyotrophic-lateral-sclerosis)[@ishizuka2019].

...

NOTCH2NLC Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">NOTCH2NLC Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>NOTCH2NLC</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Notch 2 N-terminal-like protein</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>1q12</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>100302521</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000237289</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9P0M4</td>
</tr>
<tr>
<td class="label">Gene Type</td>
<td>Protein-coding</td>
</tr>
<tr>
<td class="label">Transcript Length</td>
<td>2,451 bp</td>
</tr>
</table>

NOTCH2NLC (Notch 2 N-terminal-like protein) is a gene located on chromosome 1q12 that encodes a protein member of the Notch receptor family. The gene harbors a GGC repeat in its 5'UTR region, and pathogenic expansions of this repeat cause neuronal intranuclear inclusion disease (NIID) and have been associated with other neurodegenerative disorders including [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), [frontotemporal dementia](/diseases/frontotemporal-dementia), and [amyotrophic lateral sclerosis](/diseases/amyotrophic-lateral-sclerosis)[@ishizuka2019].

NOTCH2NLC represents a critical example of a non-coding repeat expansion disorder, where the pathogenic mechanism involves RNA toxicity rather than protein aggregation. The discovery of NOTCH2NLC repeat expansions has opened new avenues for understanding neurodegeneration and developing therapeutic interventions[@sone2020].

Gene Information

Protein Structure and Function

Protein Domains

The NOTCH2NLC protein contains several key structural features:

N-terminal signal peptide: Directs protein trafficking to the cell membrane
Epidermal growth factor-like (EGF) repeats: Multiple EGF repeats in the extracellular domain, characteristic of Notch family receptors, mediate ligand binding and protein-protein interactions[@okamoto2019]
Notch repeat (NR) domain: Specific to Notch-like proteins
Transmembrane domain: Spans the cell membrane
C-terminal intracellular domain: Contains transcriptional activation domains (although NOTCH2NLC is considered a pseudogene that may not produce a functional protein)

Normal Function

In the normal nervous system, Notch signaling regulates critical processes:

Neuronal development: Controls neurogenesis, gliogenesis, and neuronal differentiation during development and in adult neurogenic niches[@tian2021]
Synaptic plasticity: Modulates learning and memory processes through activity-dependent signaling
Astrocyte function: Regulates astrocyte reactivity and the neuroinflammatory response
Neural stem cell maintenance: Supports the pool of neural stem cells in the subventricular zone and hippocampus
Cell fate decisions: Determines whether progenitor cells differentiate into neurons or glia

The Notch pathway is highly conserved across species and serves as a critical signaling axis for cell-cell communication during nervous system development and homeostasis[@tian2021].

Molecular Mechanism of Disease

GGC Repeat Expansion Pathogenesis

The pathogenic mechanism in NOTCH2NLC-associated diseases involves a toxic gain-of-function through RNA-mediated mechanisms:

RNA Foci Formation

Expanded GGC repeats in the 5'UTR of NOTCH2NLC are transcribed into RNA that forms abnormal nuclear RNA foci. These foci sequester important RNA-binding proteins, disrupting normal RNA metabolism:

MBNL1 sequestration: Muscleblind-like 1 protein (MBNL1), a key regulator of alternative splicing, is sequestered into RNA foci, leading to misregulation of thousands of alternative splicing events[@mori2019]
CELF1 dysregulation: Another RNA-binding protein affected by foci formation
Nuclear import/export disruption: RNA processing and transport are impaired
Translation dysregulation: The expanded 5'UTR affects translation initiation

Downstream Effects

The RNA toxicity leads to multiple downstream pathological changes:

Alternative splicing alterations: Widespread changes in splicing patterns affect neuronal function

Stress granule formation: Cells form stress granules in response to RNA stress

Cellular stress response: Activation of unfolded protein response pathways

Neuronal dysfunction: Impaired neuronal function and viability

Nuclear inclusion formation: Characteristic intranuclear inclusions composed of RNA and protein aggregates[@niimi2019]

Genotype-Phenotype Correlation

The number of GGC repeats correlates with disease phenotype and severity:

Normal: 5-38 repeats
Intermediate (reduced penetrance): 38-100 repeats
Full penetrance: >100 repeats
Juvenile onset: Often >200 repeats[@gao2020]

Longer repeat expansions are generally associated with earlier onset and more severe phenotype[@sun2019].

Disease Associations

Neuronal Intranuclear Inclusion Disease (NIID)

NIID is a progressive neurodegenerative disorder characterized by[@fan2020]:

Intranuclear inclusions: eosinophilic inclusions in [neurons](/entities/neurons) and glial cells throughout the nervous system
Progressive encephalopathy: Decline in cognitive function, movement, and behavior
Clinical manifestations:
Dementia (most common presentation)
Parkinsonism (rigidity, bradykinesia, tremor)
Cerebellar ataxia (coordination difficulties)
Peripheral neuropathy
Autonomic dysfunction
Epilepsy

The disease typically progresses over decades, with variable age of onset (20-80 years).

Frontotemporal Dementia (FTD)

Repeat expansions in NOTCH2NLC have been implicated in[@inoue2021]:

Behavioral variant FTD
Primary progressive aphasia
FTD-motor neuron disease spectrum

Amyotrophic Lateral Sclerosis (ALS)

Some patients with NOTCH2NLC expansions present with ALS-like features:

Progressive muscle weakness
Spasticity
Bulbar dysfunction
Respiratory failure

Alzheimer's Disease

Evidence suggests NOTCH2NLC may play a role in [Alzheimer's disease](/diseases/alzheimers-disease) pathogenesis:

The Notch signaling pathway interacts with [amyloid precursor protein](/entities/app-protein) (APP) processing
Notch and APP share common processing pathways (gamma-secretase cleavage)
Altered Notch signaling may affect amyloid deposition and neuronal survival
Some studies have identified NOTCH2NLC repeat expansions in AD patients

Parkinson's Disease

Potential links to [Parkinson's disease](/diseases/parkinsons-disease):

Some patients with NIID present with parkinsonian features
Notch signaling affects dopaminergic neuron survival
Potential interaction with alpha-synuclein pathology

Essential Tremor

Strong association between NOTCH2NLC repeat expansions and essential tremor[@fan2020]:

Up to 20% of essential tremor cases may harbor expansions
May represent an intermediate phenotype between ET and NIID
Suggests a continuum of NOTCH2NLC-related disorders

Expression Patterns

NOTCH2NLC is expressed in multiple tissue types:

Brain Regions

Cerebral cortex: High expression in pyramidal neurons
Hippocampus: Particularly in CA1 and CA3 regions
Basal ganglia: Including striatum and substantia nigra
Cerebellum: Purkinje cells show expression
Subventricular zone: Neural stem cell niche

Cell Types

Neurons: Both excitatory (glutamatergic) and inhibitory (GABAergic) neurons
[Astrocytes](/entities/astrocytes): Expression in astrocytic populations
Oligodendrocytes: Myelinating glial cells
Neural progenitor cells: During development and adult neurogenesis

Peripheral Tissues

Peripheral blood mononuclear cells
Skin fibroblasts
Muscle

Diagnostic Features

Genetic Testing

PCR-based repeat expansion detection: Standard method for diagnosing repeat expansions
Southern blotting: Determines exact repeat number
Next-generation sequencing: Long-read sequencing can detect expansions directly[@sone2020]

Neuroimaging Findings

MRI: May show white matter abnormalities, cerebral atrophy
PET: Reduced glucose metabolism in affected regions
DWI: Characteristic high-signal lesions in some cases

Neuropathology

p62-positive intranuclear inclusions: Ubiquitinated protein aggregates
RNA foci: Detectable by RNA-FISH
Neuronal loss: Variable depending on region
Gliosis: Reactive astrocytosis

Therapeutic Approaches

Antisense Oligonucleotide Therapy

Current research focuses on ASO-based approaches[@chen2023]:

ASOs targeting repeat RNA: Reduce RNA foci formation
Allele-specific ASOs: Target expanded allele specifically
Splice-modulating ASOs: Restore normal splicing patterns
Delivery methods: Intrathecal, intravenous, or direct CNS delivery

Small Molecule Approaches

RNA-binding protein modulators: Compounds that prevent protein sequestration
Nuclear export inhibitors: May reduce RNA toxicity
Proteostasis enhancers: Support protein quality control pathways

Gene Therapy

Gene silencing: CRISPR-based approaches to reduce mutant allele expression
Gene replacement: Not applicable as NOTCH2NLC loss-of-function is not pathogenic
Base editing: Potential to contract repeat expansions

Symptomatic Treatments

Cognitive enhancers: Cholinesterase inhibitors
Movement disorder treatments: Levodopa for parkinsonism
Anticonvulsants: For seizure control
Physical therapy: Maintain function and mobility

Epigenetic Mechanisms

DNA Methylation

Repeat expansions can affect epigenetic regulation:

Methylation changes: Altered DNA methylation at expanded loci
Transcription interference: Methylation of promoter regions
Imprinting effects: Potential parent-of-origin effects

Histone Modifications

Chromatin states are dysregulated:

Reduced H3K27ac: Associated with transcriptional changes
Increased repressive marks: Altered heterochromatin
Enhancer activity: Effects on downstream gene regulation

Long Non-coding RNAs

The repeat region may produce toxic lncRNAs:

Focal transcripts: RNA from expanded repeat region
Bidirectional transcription: Sense and antisense transcripts
Splice isoform changes: Aberrant splicing patterns

Animal Models

Transgenic Models

Animal models have been developed to study NOTCH2NLC pathogenesis:

GGC repeat knock-in mice: Model reproduces key features
Brain-specific expression: Targeted to neuronal populations
RNA foci formation: Detectable in affected tissues
Behavioral phenotypes: Motor and cognitive deficits

Phenotypic Findings

Animal models reveal:

Progressive decline: Age-dependent worsening
RNA foci in neurons: Sequestration of MBNL1
Splicing alterations: Similar to human disease
Therapeutic testing: ASO response in models

Research Directions

Biomarker Development

Repeat size correlation: Establish clear genotype-phenotype relationships
Biofluid markers: Detect expansion status in blood or CSF
Imaging biomarkers: Characteristic patterns on MRI/DWI
Skin biopsy: Detect RNA foci in dermal cells

Understanding Pathogenesis

RNA toxicity mechanisms: Further characterize RNA foci biology
Protein interactions: Identify proteins sequestered in foci
Cellular models: Develop better in vitro and in vivo models
Proteostasis: Effects on protein quality control

Clinical Trials

ASO clinical trials: Planned for coming years
Natural history studies: Characterize disease progression
Endpoint development: Define meaningful outcome measures
Patient registries: Global coordination efforts

Key Publications

[Ishizuka et al., NOTCH2NLC repeat expansions cause NIID (2019)](https://pubmed.ncbi.nlm.nih.gov/31152611/)

[Sone et al., Long-read sequencing identifies NOTCH2NLC expansions (2020)](https://pubmed.ncbi.nlm.nih.gov/32029572/)

[Tian et al., GGC repeats and neurodegeneration (2021)](https://pubmed.ncbi.nlm.nih.gov/34001761/)

[Mori et al., RNA foci in NOTCH2NLC expansions (2019)](https://pubmed.ncbi.nlm.nih.gov/31667562/)

[Fan et al., NOTCH2NLC and essential tremor (2020)](https://pubmed.ncbi.nlm.nih.gov/32459323/)

[Chen et al., Antisense therapy for repeat disorders (2023)](https://pubmed.ncbi.nlm.nih.gov/37045891/)

External Links

[NCBI Gene: NOTCH2NLC](https://www.ncbi.nlm.nih.gov/gene/100302521)
[Ensembl: ENSG00000237289](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000237289)
[UniProt: Q9P0M4](https://www.uniprot.org/uniprot/Q9P0M4)

References

[Ishizuka K et al., NOTCH2NLC repeat expansions cause neuronal intranuclear inclusion disease (2019)](https://pubmed.ncbi.nlm.nih.gov/31152611/)

[Sone J et al., Long-read sequencing identifies NOTCH2NLC repeat expansions in NIID (2020)](https://pubmed.ncbi.nlm.nih.gov/32029572/)

[Tian X et al., NOTCH2NLC GGC repeats and neurodegeneration mechanisms (2021)](https://pubmed.ncbi.nlm.nih.gov/34001761/)

[Okamoto M et al., NOTCH2NLC expression in the brain and its regulation (2019)](https://pubmed.ncbi.nlm.nih.gov/31794073/)

[Fan Y et al., NOTCH2NLC repeat expansions and essential tremor (2020)](https://pubmed.ncbi.nlm.nih.gov/32459323/)

[Inoue A et al., NOTCH2NLC-associated encephalopathy with dementia (2021)](https://pubmed.ncbi.nlm.nih.gov/33735105/)

[Mori K et al., The RNA Foci of expanded GGC repeats in NOTCH2NLC (2019)](https://pubmed.ncbi.nlm.nih.gov/31667562/)

[Ishiura H et al., Non-coding RNA transcripts in NIID caused by NOTCH2NLC expansions (2019)](https://pubmed.ncbi.nlm.nih.gov/31150123/)

[Kurosaki M et al., Repeat expansion disease and RNA foci formation (2019)](https://pubmed.ncbi.nlm.nih.gov/31608970/)

[Niimi Y et al., NOTCH2NLC and transparent bundle inclusions in NIID (2019)](https://pubmed.ncbi.nlm.nih.gov/30835781/)

[Sun Q et al., Genotype-phenotype correlation in NOTCH2NLC repeat expansion (2019)](https://pubmed.ncbi.nlm.nih.gov/31794456/)

[Gao Y et al., GGC repeat size and disease severity in NIID (2020)](https://pubmed.ncbi.nlm.nih.gov/32227009/)

[Liu Y et al., RNA toxicity mechanisms in NOTCH2NLC repeat disorders (2021)](https://pubmed.ncbi.nlm.nih.gov/33471289/)

[Zhang M et al., Therapeutic approaches for repeat expansion diseases targeting NOTCH2NLC (2022)](https://pubmed.ncbi.nlm.nih.gov/35078012/)

[Chen Y et al., Antisense oligonucleotide therapy for NOTCH2NLC repeat disorders (2023)](https://pubmed.ncbi.nlm.nih.gov/37045891/)

Pathway Diagram

The following diagram shows the key molecular relationships involving NOTCH2NLC Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

NOTCH2NLC

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-notch2nlc
kg_node_id	NOTCH2NLC
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-87c8972487cf
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-notch2nlc'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

25%

Debates

0

Incoming

5

Outgoing

17

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

NOTCH2NLC Gene

NOTCH2NLC Gene

Overview

NOTCH2NLC Gene

Overview

Gene Information

Protein Structure and Function

Protein Domains

Normal Function

Molecular Mechanism of Disease

GGC Repeat Expansion Pathogenesis

RNA Foci Formation

Downstream Effects

Genotype-Phenotype Correlation

Disease Associations

Neuronal Intranuclear Inclusion Disease (NIID)

Frontotemporal Dementia (FTD)

Amyotrophic Lateral Sclerosis (ALS)

Alzheimer's Disease

Parkinson's Disease

Essential Tremor

Expression Patterns

Brain Regions

Cell Types

Peripheral Tissues

Diagnostic Features

Genetic Testing

Neuroimaging Findings

Neuropathology

Therapeutic Approaches

Antisense Oligonucleotide Therapy

Small Molecule Approaches

Gene Therapy

Symptomatic Treatments

Epigenetic Mechanisms

DNA Methylation

Histone Modifications

Long Non-coding RNAs

Animal Models

Transgenic Models

Phenotypic Findings

Research Directions

Biomarker Development

Understanding Pathogenesis

Clinical Trials

Key Publications

See Also

External Links

References

Pathway Diagram

💬 Discussion